Systemic neoadjuvant chemotherapy in non-resectable invasive squamous cell carcinoma of ocular surface.

NAC appears to be an exciting option for management of surgically challenging cases of invasive OSSN and may be helpful in avoiding orbital exenteration. However, more studies are required to explore this treatment option.